Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
793 studies found for:    "Tuberculosis"
Show Display Options
Rank Status Study
1 Completed Tuberculosis Immunity in Children
Condition: Tuberculosis
Intervention:
2 Completed
Has Results
Tuberculosis Treatment Shortening Trial
Condition: Tuberculosis
Interventions: Drug: Pyrazinamide;   Drug: Rifampin;   Drug: Isoniazid;   Drug: Ethambutol
3 Completed Evaluation of a LAM FLISA for the Diagnosis of Tuberculosis
Condition: Tuberculosis
Intervention:
4 Completed Pharmacokinetic Interaction Study in Indonesian Tuberculosis Patients Indonesia
Condition: Tuberculosis
Intervention: Drug: moxifloxacin
5 Unknown  Diagnosis of Active Tuberculosis by ELISPOT
Condition: Tuberculosis
Intervention:
6 Completed
Has Results
Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults.
Condition: Tuberculosis
Interventions: Biological: GSK's candidate Mycobacterium tuberculosis vaccine 692342;   Biological: Control vaccine with the adjuvant system.;   Biological: Control vaccine with physiological saline
7 Completed Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Healthy Infants
Condition: Tuberculosis
Interventions: Biological: GSK's investigational vaccine 692342;   Biological: Tritanrix™ HB+Hib;   Biological: Prevnar™;   Biological: Polio Sabin™;   Biological: Menjugate™
8 Completed Determining the Impact of Enhanced Case Finding on Tuberculosis Notification in The Gambia
Condition: Tuberculosis
Intervention: Behavioral: Behavioral: community sensitization
9 Completed The Role of Routine Bacterial Culture Including Tuberculosis During Bronchoscopy: A Prospective Study
Condition: Tuberculosis
Intervention:
10 Completed
Has Results
Safety and Immunogenicity Study of GSK Biologicals Tuberculosis Vaccines (692342) to Healthy Adults
Condition: Tuberculosis
Interventions: Biological: GSK Biologicals' Candidate Tuberculosis Vaccines (692342) - different formulations;   Biological: Control vaccine with the adjuvant system.;   Biological: Control vaccine with physiological saline
11 Completed
Has Results
Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Healthy HIV Negative Adolescents
Condition: Tuberculosis
Interventions: Biological: GSK's investigational vaccine 692342;   Biological: Placebo
12 Unknown  Rapid Diagnosis of Pulmonary Tuberculosis
Condition: Tuberculosis
Interventions: Drug: Salbutamol;   Drug: Sodium chloride 5%
13 Terminated Effect of Multivitamin Supplements on Clinical and Immunological Response in Childhood Tuberculosis
Condition: Tuberculosis
Interventions: Dietary Supplement: Multivitamin supplement containing vitamins B, C, and E;   Drug: Placebo
14 Completed The Role of High Resolution-Computed Tomography (CT) in Tuberculosis (TB) Outbreak Investigation
Condition: Tuberculosis
Intervention:
15 Completed TMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-Smear Positive Tuberculosis
Condition: Tuberculosis
Intervention: Drug: TMC207
16 Recruiting Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection
Condition: Tuberculosis
Intervention: Device: CST001
17 Unknown  Spatial Epidemiology of Tuberculosis (TB) Infection
Condition: Tuberculosis
Intervention:
18 Completed Treatment Duration for Abdominal Tuberculosis
Condition: Tuberculosis
Interventions: Drug: RNTCP Category I treatment for 6 months;   Drug: RNTCP Category I treatment for 9months
19 Unknown  Follow up of Autoantibodies in Active Tuberculosis
Condition: Tuberculosis
Intervention:
20 Completed Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination
Condition: Tuberculosis
Interventions: Biological: BCG strain Danish;   Drug: Isoniazid

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.